ANI Pharmaceuticals, Inc. (ANIP) — Analysis Summary
ANI Pharmaceuticals, Inc. (ANIP) has a market cap of $1.78B with year-over-year revenue growth of +43.8%. Net margin stands at 8.9%. The stock trades at a P/E ratio of 19.4.
Key Takeaways
- Revenue changed +43.8% year-over-year
- Net margin of 8.9%
- P/E ratio of 19.4
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, ANIP posted revenue growth of +43.8% and trades at a P/E of 19.4.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.